August 29, 2013
The U.S. Department of Health and Human Services on Wednesday hit back at a challenge by the former CEO of InterMune Inc. to his five-year exclusion from federal health programs following his conviction of fraudulently marketing the drug Actimmune, telling a California federal court the exclusion was legally valid.